PMS40 COST-EFFECTIVENESS ANALYSIS OF ANNUAL DOSE OF ZOLEDRONIC ACID VERSUS ORALLY ADMINISTERED BISPHOSPHONATES IN PREVENTION OF OSTEOPOROTIC FRACTURES IN CZECH POST-MENOPAUSALWOMEN
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66809-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)66809-X/fulltext
Title :
PMS40 COST-EFFECTIVENESS ANALYSIS OF ANNUAL DOSE OF ZOLEDRONIC ACID VERSUS ORALLY ADMINISTERED BISPHOSPHONATES IN PREVENTION OF OSTEOPOROTIC FRACTURES IN CZECH POST-MENOPAUSALWOMEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66809-X&doi=10.1016/S1098-3015(10)66809-X
First page :
Section Title :
Open access? :
No
Section Order :
647